Analyst Recommendations

CLSA analyst issues OUTPERFORM recommendation for BIDU on November 8, 2024 05:43AM ET. The previous analyst recommendation was Outperform.BIDU was trading at $93.525 at issue of the analyst...

November 8, 2024   BIDU 0.13%

Bernstein analyst issues OUTPERFORM recommendation for TCOM on November 4, 2024 10:48AM ET. TCOM was trading at $67.24 at issue of the analyst recommendation.The overall analyst consensus :...

November 5, 2024   TCOM -3.49%

H.C. Wainwright analyst issues BUY recommendation for CMPS on November 4, 2024 11:43AM ET. The previous analyst recommendation was Buy.CMPS was trading at $4.68 at issue of the...

November 5, 2024   CMPS 4.94%

Cowen & Co. analyst issues HOLD recommendation for TTE on November 4, 2024 02:16PM ET. The previous analyst recommendation was Hold.TTE was trading at $62.99 at issue of...

November 5, 2024   TTE -2.06%

Deutsche Bank analyst issues HOLD recommendation for NA on November 4, 2024 02:56PM ET. The previous analyst recommendation was Hold.NA was trading at $4.6 at issue of the...

November 5, 2024   NA 1.03%

Susquehanna analyst issues NEUTRAL recommendation for CRTO on October 31, 2024 08:35AM ET. The previous analyst recommendation was Neutral.CRTO was trading at $33.59 at issue of the analyst...

October 31, 2024   CRTO -0.29%

Lake Street analyst issues BUY recommendation for MDXH on October 31, 2024 08:43AM ET. MDXH was trading at $2.04 at issue of the analyst recommendation.The overall analyst consensus...

October 31, 2024   MDXH -3.33%

Craig-Hallum analyst issues BUY recommendation for STM on October 31, 2024 08:49AM ET. The previous analyst recommendation was Buy.STM was trading at $27.07 at issue of the analyst...

October 31, 2024   STM 6.86%

Oppenheimer analyst issues OUTPERFORM recommendation for AVDL on October 31, 2024 07:53AM ET. The previous analyst recommendation was Outperform.AVDL was trading at $12.91 at issue of the analyst...

October 31, 2024   STM 6.86%

Guggenheim analyst issues NEUTRAL recommendation for GSK on October 31, 2024 05:02AM ET. The previous analyst recommendation was Buy.GSK was trading at $37.01 at issue of the analyst...

October 31, 2024   GSK -2.84%